The objective of the proposed research is to reveal fundamental relationships between chemical structure and mutagenic/carcinogenic activity, and to provide insight into the molecular mechanisms by which carcinogens after DNA, cause mutations and result in cancer. Using several site-specifically adducted oligonucleotides, we will compare how the structure, conformation and position of the DNA adduct affect the fidelity, processivity and efficiency of DNA polymerases in vitro. We will also utilize these oligonucleotides in an in vivo model to analyze how these characteristics of an adduct affect the induced mutation. These oligomers contain the exact sequence context of two in vivo hotspots for (+)-BPDE (an ultimate carcinogenic metabolite of benzo[a]pyrene) and have the (+)-BPDE modification on the purine base either at or next to the hotspot. Nonadducted and (-)-BPDE (a weak or noncarcinogenic enantiomer) adducted oligomers will also be prepared for comparative studies.
The specific aims are to: 1. Study the mutagenic effects of site-specific adducts by the primer extension reaction with the replicative DNA polymerases from human and the lesion bypass polymerase from yeast. We will a) Prepare site-specifically adducted 59- mer templates. b) Determine the effects of BPDE adduction on the fidelity, processivity and efficiency of DNA polymerases. c) Compare the effects of BPDE stereochemistry on DNA polymerase activities. d) Investigate effects of adduct position on DNA polymerase activities. 2. Study the mutagenic effects of site-specific adducts in vivo by transfection assays in mammalian cells. We will a) Construct several eukaryotic expression vectors so that each contains the entire coding region of the hprt gene and a single site-specific (+)- or (-)-BPDE adduct at or next to a hotspot in the hprt cDNA sequence. b) Determine the mutagenic effect of the site-specific adduct in vivo by transfecting these hprt expression vectors into V-79 cells. We will then analyze mutations in stable transformants and compare them with mutations obtained from our earlier random mutagenesis studies in V-79 cells. We will subsequently examine how the adduct position and chirality affect the outcome of the mutation formation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA076425-03
Application #
6329015
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Velazquez, Jose M
Project Start
1998-12-24
Project End
2002-11-30
Budget Start
2000-12-01
Budget End
2002-11-30
Support Year
3
Fiscal Year
2001
Total Cost
$176,286
Indirect Cost
Name
Rutgers University
Department
Biology
Type
Schools of Pharmacy
DUNS #
001912864
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Simhadri, Srilatha; Kramata, Pavel; Zajc, Barbara et al. (2002) Benzo[a]pyrene diol epoxide-deoxyguanosine adducts are accurately bypassed by yeast DNA polymerase zeta in vitro. Mutat Res 508:137-45